The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global High-throughput Screening (HTS) Assay Market Research Report 2025
Synopsis
High-throughput screening (HTS) assay is a method used in drug discovery and other fields to quickly and efficiently test a large number of compounds or samples for a specific biological activity. HTS assays are typically automated and can screen thousands to millions of compounds in a relatively short amount of time. HTS assays are often used in the early stages of drug discovery to identify potential lead compounds that show promising activity against a target of interest. These assays can be used to screen for a wide range of biological activities, such as enzyme inhibition, receptor binding, or cell-based assays. There are several different types of HTS assays, including biochemical assays, cell-based assays, and phenotypic assays. Biochemical assays measure the activity of a specific enzyme or protein, while cell-based assays use living cells to measure the effect of compounds on cellular processes. Phenotypic assays measure a specific observable phenotype, such as cell growth or morphology. Overall, HTS assays are a powerful tool in drug discovery and other fields, allowing researchers to quickly and efficiently screen large libraries of compounds to identify potential drug candidates.
The global High-throughput Screening (HTS) Assay market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for High-throughput Screening (HTS) Assay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for High-throughput Screening (HTS) Assay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for High-throughput Screening (HTS) Assay in Drug Discovery is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of High-throughput Screening (HTS) Assay include Thermo Fisher Scientific, PerkinElmer, Agilent Technologies, Beckman Coulter, Tecan Group, Hamilton Company, Bio-Rad Laboratories, BMG LABTECH, Promega Corporation, Danaher, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for High-throughput Screening (HTS) Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding High-throughput Screening (HTS) Assay.
The High-throughput Screening (HTS) Assay market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global High-throughput Screening (HTS) Assay market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the High-throughput Screening (HTS) Assay companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
PerkinElmer
Agilent Technologies
Beckman Coulter
Tecan Group
Hamilton Company
Bio-Rad Laboratories
BMG LABTECH
Promega Corporation
Danaher
Axxam
Merck Millipore
Aurora Biomed
InvivoGen
Biotek Instruments
BPS Bioscience
Eurofins Discovery
Cayman Chemical
Segment by Type
Biochemical Assay
Phenotyping Assay
Binding Assay
Aell-based Assay
Others
Segment by Application
Drug Discovery
Identifying New Drug Targets
Toxicology Research
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of High-throughput Screening (HTS) Assay company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
High-throughput screening (HTS) assay is a method used in drug discovery and other fields to quickly and efficiently test a large number of compounds or samples for a specific biological activity. HTS assays are typically automated and can screen thousands to millions of compounds in a relatively short amount of time. HTS assays are often used in the early stages of drug discovery to identify potential lead compounds that show promising activity against a target of interest. These assays can be used to screen for a wide range of biological activities, such as enzyme inhibition, receptor binding, or cell-based assays. There are several different types of HTS assays, including biochemical assays, cell-based assays, and phenotypic assays. Biochemical assays measure the activity of a specific enzyme or protein, while cell-based assays use living cells to measure the effect of compounds on cellular processes. Phenotypic assays measure a specific observable phenotype, such as cell growth or morphology. Overall, HTS assays are a powerful tool in drug discovery and other fields, allowing researchers to quickly and efficiently screen large libraries of compounds to identify potential drug candidates.
The global High-throughput Screening (HTS) Assay market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for High-throughput Screening (HTS) Assay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for High-throughput Screening (HTS) Assay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for High-throughput Screening (HTS) Assay in Drug Discovery is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of High-throughput Screening (HTS) Assay include Thermo Fisher Scientific, PerkinElmer, Agilent Technologies, Beckman Coulter, Tecan Group, Hamilton Company, Bio-Rad Laboratories, BMG LABTECH, Promega Corporation, Danaher, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for High-throughput Screening (HTS) Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding High-throughput Screening (HTS) Assay.
The High-throughput Screening (HTS) Assay market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global High-throughput Screening (HTS) Assay market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the High-throughput Screening (HTS) Assay companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
PerkinElmer
Agilent Technologies
Beckman Coulter
Tecan Group
Hamilton Company
Bio-Rad Laboratories
BMG LABTECH
Promega Corporation
Danaher
Axxam
Merck Millipore
Aurora Biomed
InvivoGen
Biotek Instruments
BPS Bioscience
Eurofins Discovery
Cayman Chemical
Segment by Type
Biochemical Assay
Phenotyping Assay
Binding Assay
Aell-based Assay
Others
Segment by Application
Drug Discovery
Identifying New Drug Targets
Toxicology Research
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of High-throughput Screening (HTS) Assay company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global High-throughput Screening (HTS) Assay Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Biochemical Assay
1.2.3 Phenotyping Assay
1.2.4 Binding Assay
1.2.5 Aell-based Assay
1.2.6 Others
1.3 Market by Application
1.3.1 Global High-throughput Screening (HTS) Assay Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Discovery
1.3.3 Identifying New Drug Targets
1.3.4 Toxicology Research
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global High-throughput Screening (HTS) Assay Market Perspective (2019-2030)
2.2 Global High-throughput Screening (HTS) Assay Growth Trends by Region
2.2.1 Global High-throughput Screening (HTS) Assay Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 High-throughput Screening (HTS) Assay Historic Market Size by Region (2019-2024)
2.2.3 High-throughput Screening (HTS) Assay Forecasted Market Size by Region (2025-2030)
2.3 High-throughput Screening (HTS) Assay Market Dynamics
2.3.1 High-throughput Screening (HTS) Assay Industry Trends
2.3.2 High-throughput Screening (HTS) Assay Market Drivers
2.3.3 High-throughput Screening (HTS) Assay Market Challenges
2.3.4 High-throughput Screening (HTS) Assay Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top High-throughput Screening (HTS) Assay Players by Revenue
3.1.1 Global Top High-throughput Screening (HTS) Assay Players by Revenue (2019-2024)
3.1.2 Global High-throughput Screening (HTS) Assay Revenue Market Share by Players (2019-2024)
3.2 Global High-throughput Screening (HTS) Assay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by High-throughput Screening (HTS) Assay Revenue
3.4 Global High-throughput Screening (HTS) Assay Market Concentration Ratio
3.4.1 Global High-throughput Screening (HTS) Assay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by High-throughput Screening (HTS) Assay Revenue in 2023
3.5 Global Key Players of High-throughput Screening (HTS) Assay Head office and Area Served
3.6 Global Key Players of High-throughput Screening (HTS) Assay, Product and Application
3.7 Global Key Players of High-throughput Screening (HTS) Assay, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 High-throughput Screening (HTS) Assay Breakdown Data by Type
4.1 Global High-throughput Screening (HTS) Assay Historic Market Size by Type (2019-2024)
4.2 Global High-throughput Screening (HTS) Assay Forecasted Market Size by Type (2025-2030)
5 High-throughput Screening (HTS) Assay Breakdown Data by Application
5.1 Global High-throughput Screening (HTS) Assay Historic Market Size by Application (2019-2024)
5.2 Global High-throughput Screening (HTS) Assay Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America High-throughput Screening (HTS) Assay Market Size (2019-2030)
6.2 North America High-throughput Screening (HTS) Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America High-throughput Screening (HTS) Assay Market Size by Country (2019-2024)
6.4 North America High-throughput Screening (HTS) Assay Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe High-throughput Screening (HTS) Assay Market Size (2019-2030)
7.2 Europe High-throughput Screening (HTS) Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe High-throughput Screening (HTS) Assay Market Size by Country (2019-2024)
7.4 Europe High-throughput Screening (HTS) Assay Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific High-throughput Screening (HTS) Assay Market Size (2019-2030)
8.2 Asia-Pacific High-throughput Screening (HTS) Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific High-throughput Screening (HTS) Assay Market Size by Region (2019-2024)
8.4 Asia-Pacific High-throughput Screening (HTS) Assay Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America High-throughput Screening (HTS) Assay Market Size (2019-2030)
9.2 Latin America High-throughput Screening (HTS) Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America High-throughput Screening (HTS) Assay Market Size by Country (2019-2024)
9.4 Latin America High-throughput Screening (HTS) Assay Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa High-throughput Screening (HTS) Assay Market Size (2019-2030)
10.2 Middle East & Africa High-throughput Screening (HTS) Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa High-throughput Screening (HTS) Assay Market Size by Country (2019-2024)
10.4 Middle East & Africa High-throughput Screening (HTS) Assay Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific High-throughput Screening (HTS) Assay Introduction
11.1.4 Thermo Fisher Scientific Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 PerkinElmer
11.2.1 PerkinElmer Company Details
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer High-throughput Screening (HTS) Assay Introduction
11.2.4 PerkinElmer Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.2.5 PerkinElmer Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies High-throughput Screening (HTS) Assay Introduction
11.3.4 Agilent Technologies Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.3.5 Agilent Technologies Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Details
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter High-throughput Screening (HTS) Assay Introduction
11.4.4 Beckman Coulter Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.4.5 Beckman Coulter Recent Development
11.5 Tecan Group
11.5.1 Tecan Group Company Details
11.5.2 Tecan Group Business Overview
11.5.3 Tecan Group High-throughput Screening (HTS) Assay Introduction
11.5.4 Tecan Group Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.5.5 Tecan Group Recent Development
11.6 Hamilton Company
11.6.1 Hamilton Company Company Details
11.6.2 Hamilton Company Business Overview
11.6.3 Hamilton Company High-throughput Screening (HTS) Assay Introduction
11.6.4 Hamilton Company Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.6.5 Hamilton Company Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories High-throughput Screening (HTS) Assay Introduction
11.7.4 Bio-Rad Laboratories Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 BMG LABTECH
11.8.1 BMG LABTECH Company Details
11.8.2 BMG LABTECH Business Overview
11.8.3 BMG LABTECH High-throughput Screening (HTS) Assay Introduction
11.8.4 BMG LABTECH Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.8.5 BMG LABTECH Recent Development
11.9 Promega Corporation
11.9.1 Promega Corporation Company Details
11.9.2 Promega Corporation Business Overview
11.9.3 Promega Corporation High-throughput Screening (HTS) Assay Introduction
11.9.4 Promega Corporation Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.9.5 Promega Corporation Recent Development
11.10 Danaher
11.10.1 Danaher Company Details
11.10.2 Danaher Business Overview
11.10.3 Danaher High-throughput Screening (HTS) Assay Introduction
11.10.4 Danaher Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.10.5 Danaher Recent Development
11.11 Axxam
11.11.1 Axxam Company Details
11.11.2 Axxam Business Overview
11.11.3 Axxam High-throughput Screening (HTS) Assay Introduction
11.11.4 Axxam Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.11.5 Axxam Recent Development
11.12 Merck Millipore
11.12.1 Merck Millipore Company Details
11.12.2 Merck Millipore Business Overview
11.12.3 Merck Millipore High-throughput Screening (HTS) Assay Introduction
11.12.4 Merck Millipore Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.12.5 Merck Millipore Recent Development
11.13 Aurora Biomed
11.13.1 Aurora Biomed Company Details
11.13.2 Aurora Biomed Business Overview
11.13.3 Aurora Biomed High-throughput Screening (HTS) Assay Introduction
11.13.4 Aurora Biomed Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.13.5 Aurora Biomed Recent Development
11.14 InvivoGen
11.14.1 InvivoGen Company Details
11.14.2 InvivoGen Business Overview
11.14.3 InvivoGen High-throughput Screening (HTS) Assay Introduction
11.14.4 InvivoGen Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.14.5 InvivoGen Recent Development
11.15 Biotek Instruments
11.15.1 Biotek Instruments Company Details
11.15.2 Biotek Instruments Business Overview
11.15.3 Biotek Instruments High-throughput Screening (HTS) Assay Introduction
11.15.4 Biotek Instruments Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.15.5 Biotek Instruments Recent Development
11.16 BPS Bioscience
11.16.1 BPS Bioscience Company Details
11.16.2 BPS Bioscience Business Overview
11.16.3 BPS Bioscience High-throughput Screening (HTS) Assay Introduction
11.16.4 BPS Bioscience Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.16.5 BPS Bioscience Recent Development
11.17 Eurofins Discovery
11.17.1 Eurofins Discovery Company Details
11.17.2 Eurofins Discovery Business Overview
11.17.3 Eurofins Discovery High-throughput Screening (HTS) Assay Introduction
11.17.4 Eurofins Discovery Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.17.5 Eurofins Discovery Recent Development
11.18 Cayman Chemical
11.18.1 Cayman Chemical Company Details
11.18.2 Cayman Chemical Business Overview
11.18.3 Cayman Chemical High-throughput Screening (HTS) Assay Introduction
11.18.4 Cayman Chemical Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.18.5 Cayman Chemical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global High-throughput Screening (HTS) Assay Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Biochemical Assay
Table 3. Key Players of Phenotyping Assay
Table 4. Key Players of Binding Assay
Table 5. Key Players of Aell-based Assay
Table 6. Key Players of Others
Table 7. Global High-throughput Screening (HTS) Assay Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global High-throughput Screening (HTS) Assay Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global High-throughput Screening (HTS) Assay Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global High-throughput Screening (HTS) Assay Market Share by Region (2019-2024)
Table 11. Global High-throughput Screening (HTS) Assay Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global High-throughput Screening (HTS) Assay Market Share by Region (2025-2030)
Table 13. High-throughput Screening (HTS) Assay Market Trends
Table 14. High-throughput Screening (HTS) Assay Market Drivers
Table 15. High-throughput Screening (HTS) Assay Market Challenges
Table 16. High-throughput Screening (HTS) Assay Market Restraints
Table 17. Global High-throughput Screening (HTS) Assay Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global High-throughput Screening (HTS) Assay Market Share by Players (2019-2024)
Table 19. Global Top High-throughput Screening (HTS) Assay Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in High-throughput Screening (HTS) Assay as of 2023)
Table 20. Ranking of Global Top High-throughput Screening (HTS) Assay Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by High-throughput Screening (HTS) Assay Revenue (CR5 and HHI) & (2019-2024)
Table 22. Global Key Players of High-throughput Screening (HTS) Assay, Headquarters and Area Served
Table 23. Global Key Players of High-throughput Screening (HTS) Assay, Product and Application
Table 24. Global Key Players of High-throughput Screening (HTS) Assay, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global High-throughput Screening (HTS) Assay Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global High-throughput Screening (HTS) Assay Revenue Market Share by Type (2019-2024)
Table 28. Global High-throughput Screening (HTS) Assay Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global High-throughput Screening (HTS) Assay Revenue Market Share by Type (2025-2030)
Table 30. Global High-throughput Screening (HTS) Assay Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global High-throughput Screening (HTS) Assay Revenue Market Share by Application (2019-2024)
Table 32. Global High-throughput Screening (HTS) Assay Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global High-throughput Screening (HTS) Assay Revenue Market Share by Application (2025-2030)
Table 34. North America High-throughput Screening (HTS) Assay Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America High-throughput Screening (HTS) Assay Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America High-throughput Screening (HTS) Assay Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe High-throughput Screening (HTS) Assay Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe High-throughput Screening (HTS) Assay Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe High-throughput Screening (HTS) Assay Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific High-throughput Screening (HTS) Assay Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific High-throughput Screening (HTS) Assay Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific High-throughput Screening (HTS) Assay Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America High-throughput Screening (HTS) Assay Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America High-throughput Screening (HTS) Assay Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America High-throughput Screening (HTS) Assay Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa High-throughput Screening (HTS) Assay Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa High-throughput Screening (HTS) Assay Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa High-throughput Screening (HTS) Assay Market Size by Country (2025-2030) & (US$ Million)
Table 49. Thermo Fisher Scientific Company Details
Table 50. Thermo Fisher Scientific Business Overview
Table 51. Thermo Fisher Scientific High-throughput Screening (HTS) Assay Product
Table 52. Thermo Fisher Scientific Revenue in High-throughput Screening (HTS) Assay Business (2019-2024) & (US$ Million)
Table 53. Thermo Fisher Scientific Recent Development
Table 54. PerkinElmer Company Details
Table 55. PerkinElmer Business Overview
Table 56. PerkinElmer High-throughput Screening (HTS) Assay Product
Table 57. PerkinElmer Revenue in High-throughput Screening (HTS) Assay Business (2019-2024) & (US$ Million)
Table 58. PerkinElmer Recent Development
Table 59. Agilent Technologies Company Details
Table 60. Agilent Technologies Business Overview
Table 61. Agilent Technologies High-throughput Screening (HTS) Assay Product
Table 62. Agilent Technologies Revenue in High-throughput Screening (HTS) Assay Business (2019-2024) & (US$ Million)
Table 63. Agilent Technologies Recent Development
Table 64. Beckman Coulter Company Details
Table 65. Beckman Coulter Business Overview
Table 66. Beckman Coulter High-throughput Screening (HTS) Assay Product
Table 67. Beckman Coulter Revenue in High-throughput Screening (HTS) Assay Business (2019-2024) & (US$ Million)
Table 68. Beckman Coulter Recent Development
Table 69. Tecan Group Company Details
Table 70. Tecan Group Business Overview
Table 71. Tecan Group High-throughput Screening (HTS) Assay Product
Table 72. Tecan Group Revenue in High-throughput Screening (HTS) Assay Business (2019-2024) & (US$ Million)
Table 73. Tecan Group Recent Development
Table 74. Hamilton Company Company Details
Table 75. Hamilton Company Business Overview
Table 76. Hamilton Company High-throughput Screening (HTS) Assay Product
Table 77. Hamilton Company Revenue in High-throughput Screening (HTS) Assay Business (2019-2024) & (US$ Million)
Table 78. Hamilton Company Recent Development
Table 79. Bio-Rad Laboratories Company Details
Table 80. Bio-Rad Laboratories Business Overview
Table 81. Bio-Rad Laboratories High-throughput Screening (HTS) Assay Product
Table 82. Bio-Rad Laboratories Revenue in High-throughput Screening (HTS) Assay Business (2019-2024) & (US$ Million)
Table 83. Bio-Rad Laboratories Recent Development
Table 84. BMG LABTECH Company Details
Table 85. BMG LABTECH Business Overview
Table 86. BMG LABTECH High-throughput Screening (HTS) Assay Product
Table 87. BMG LABTECH Revenue in High-throughput Screening (HTS) Assay Business (2019-2024) & (US$ Million)
Table 88. BMG LABTECH Recent Development
Table 89. Promega Corporation Company Details
Table 90. Promega Corporation Business Overview
Table 91. Promega Corporation High-throughput Screening (HTS) Assay Product
Table 92. Promega Corporation Revenue in High-throughput Screening (HTS) Assay Business (2019-2024) & (US$ Million)
Table 93. Promega Corporation Recent Development
Table 94. Danaher Company Details
Table 95. Danaher Business Overview
Table 96. Danaher High-throughput Screening (HTS) Assay Product
Table 97. Danaher Revenue in High-throughput Screening (HTS) Assay Business (2019-2024) & (US$ Million)
Table 98. Danaher Recent Development
Table 99. Axxam Company Details
Table 100. Axxam Business Overview
Table 101. Axxam High-throughput Screening (HTS) Assay Product
Table 102. Axxam Revenue in High-throughput Screening (HTS) Assay Business (2019-2024) & (US$ Million)
Table 103. Axxam Recent Development
Table 104. Merck Millipore Company Details
Table 105. Merck Millipore Business Overview
Table 106. Merck Millipore High-throughput Screening (HTS) Assay Product
Table 107. Merck Millipore Revenue in High-throughput Screening (HTS) Assay Business (2019-2024) & (US$ Million)
Table 108. Merck Millipore Recent Development
Table 109. Aurora Biomed Company Details
Table 110. Aurora Biomed Business Overview
Table 111. Aurora Biomed High-throughput Screening (HTS) Assay Product
Table 112. Aurora Biomed Revenue in High-throughput Screening (HTS) Assay Business (2019-2024) & (US$ Million)
Table 113. Aurora Biomed Recent Development
Table 114. InvivoGen Company Details
Table 115. InvivoGen Business Overview
Table 116. InvivoGen High-throughput Screening (HTS) Assay Product
Table 117. InvivoGen Revenue in High-throughput Screening (HTS) Assay Business (2019-2024) & (US$ Million)
Table 118. InvivoGen Recent Development
Table 119. Biotek Instruments Company Details
Table 120. Biotek Instruments Business Overview
Table 121. Biotek Instruments High-throughput Screening (HTS) Assay Product
Table 122. Biotek Instruments Revenue in High-throughput Screening (HTS) Assay Business (2019-2024) & (US$ Million)
Table 123. Biotek Instruments Recent Development
Table 124. BPS Bioscience Company Details
Table 125. BPS Bioscience Business Overview
Table 126. BPS Bioscience High-throughput Screening (HTS) Assay Product
Table 127. BPS Bioscience Revenue in High-throughput Screening (HTS) Assay Business (2019-2024) & (US$ Million)
Table 128. BPS Bioscience Recent Development
Table 129. Eurofins Discovery Company Details
Table 130. Eurofins Discovery Business Overview
Table 131. Eurofins Discovery High-throughput Screening (HTS) Assay Product
Table 132. Eurofins Discovery Revenue in High-throughput Screening (HTS) Assay Business (2019-2024) & (US$ Million)
Table 133. Eurofins Discovery Recent Development
Table 134. Cayman Chemical Company Details
Table 135. Cayman Chemical Business Overview
Table 136. Cayman Chemical High-throughput Screening (HTS) Assay Product
Table 137. Cayman Chemical Revenue in High-throughput Screening (HTS) Assay Business (2019-2024) & (US$ Million)
Table 138. Cayman Chemical Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 142. Authors List of This Report
List of Figures
Figure 1. High-throughput Screening (HTS) Assay Picture
Figure 2. Global High-throughput Screening (HTS) Assay Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global High-throughput Screening (HTS) Assay Market Share by Type: 2023 VS 2030
Figure 4. Biochemical Assay Features
Figure 5. Phenotyping Assay Features
Figure 6. Binding Assay Features
Figure 7. Aell-based Assay Features
Figure 8. Others Features
Figure 9. Global High-throughput Screening (HTS) Assay Market Size by Application (2024-2030) & (US$ Million)
Figure 10. Global High-throughput Screening (HTS) Assay Market Share by Application: 2023 VS 2030
Figure 11. Drug Discovery Case Studies
Figure 12. Identifying New Drug Targets Case Studies
Figure 13. Toxicology Research Case Studies
Figure 14. Others Case Studies
Figure 15. High-throughput Screening (HTS) Assay Report Years Considered
Figure 16. Global High-throughput Screening (HTS) Assay Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global High-throughput Screening (HTS) Assay Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global High-throughput Screening (HTS) Assay Market Share by Region: 2023 VS 2030
Figure 19. Global High-throughput Screening (HTS) Assay Market Share by Players in 2023
Figure 20. Global Top High-throughput Screening (HTS) Assay Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in High-throughput Screening (HTS) Assay as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by High-throughput Screening (HTS) Assay Revenue in 2023
Figure 22. North America High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America High-throughput Screening (HTS) Assay Market Share by Country (2019-2030)
Figure 24. United States High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe High-throughput Screening (HTS) Assay Market Share by Country (2019-2030)
Figure 28. Germany High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific High-throughput Screening (HTS) Assay Market Share by Region (2019-2030)
Figure 36. China High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America High-throughput Screening (HTS) Assay Market Share by Country (2019-2030)
Figure 44. Mexico High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa High-throughput Screening (HTS) Assay Market Share by Country (2019-2030)
Figure 48. Turkey High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. UAE High-throughput Screening (HTS) Assay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in High-throughput Screening (HTS) Assay Business (2019-2024)
Figure 52. PerkinElmer Revenue Growth Rate in High-throughput Screening (HTS) Assay Business (2019-2024)
Figure 53. Agilent Technologies Revenue Growth Rate in High-throughput Screening (HTS) Assay Business (2019-2024)
Figure 54. Beckman Coulter Revenue Growth Rate in High-throughput Screening (HTS) Assay Business (2019-2024)
Figure 55. Tecan Group Revenue Growth Rate in High-throughput Screening (HTS) Assay Business (2019-2024)
Figure 56. Hamilton Company Revenue Growth Rate in High-throughput Screening (HTS) Assay Business (2019-2024)
Figure 57. Bio-Rad Laboratories Revenue Growth Rate in High-throughput Screening (HTS) Assay Business (2019-2024)
Figure 58. BMG LABTECH Revenue Growth Rate in High-throughput Screening (HTS) Assay Business (2019-2024)
Figure 59. Promega Corporation Revenue Growth Rate in High-throughput Screening (HTS) Assay Business (2019-2024)
Figure 60. Danaher Revenue Growth Rate in High-throughput Screening (HTS) Assay Business (2019-2024)
Figure 61. Axxam Revenue Growth Rate in High-throughput Screening (HTS) Assay Business (2019-2024)
Figure 62. Merck Millipore Revenue Growth Rate in High-throughput Screening (HTS) Assay Business (2019-2024)
Figure 63. Aurora Biomed Revenue Growth Rate in High-throughput Screening (HTS) Assay Business (2019-2024)
Figure 64. InvivoGen Revenue Growth Rate in High-throughput Screening (HTS) Assay Business (2019-2024)
Figure 65. Biotek Instruments Revenue Growth Rate in High-throughput Screening (HTS) Assay Business (2019-2024)
Figure 66. BPS Bioscience Revenue Growth Rate in High-throughput Screening (HTS) Assay Business (2019-2024)
Figure 67. Eurofins Discovery Revenue Growth Rate in High-throughput Screening (HTS) Assay Business (2019-2024)
Figure 68. Cayman Chemical Revenue Growth Rate in High-throughput Screening (HTS) Assay Business (2019-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
